SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-10-004794
Filing Date
2010-01-26
Accepted
2010-01-26 20:03:37
Documents
1
Period of Report
2010-01-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 - DUNAYEVICH rrd263558.html 4  
1 FORM 4 - DUNAYEVICH rrd263558.xml 4 4271
  Complete submission text file 0001181431-10-004794.txt   6115
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Issuer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OREXIGEN THERAPEUTICS, INC. 12481 HIGH BLUFF DRIVE, SUITE 160 SAN DIEGO CA 92130
Business Address
DUNAYEVICH EDUARDO (Reporting) CIK: 0001396783 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33415 | Film No.: 10548867